Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...
Anumana’s AI-enabled algorithm for the early detection of pulmonary hypertension (PH) has been cleared for use by the FDA.
The Numerical Mathematics Consortium today announced the latest revision to a technical specification introduced earlier this year that defines an open mathematics semantics standard for numerical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results